deutivacaftor

Italy

Drugs containing this active substance

  • ALYFTREK

    Alyftrek is intended for the long-term treatment of people aged 6 years and older with cystic fibrosis (CF) who have at least one drug-responsive CFTR gene mutation. It works by improving lung function and breathing.

    Form: tablets, film-coated

    Active substance Dosage
    deutivacaftor -
    tezacaftor -
    vanzacaftor -

    ATC: R07AX33

    Manufacturer: VERTEX PHARMACEUTICALS (IRELAND) LIMITED